Avanos Medical Inc (AVNS)
19.13
-0.36
(-1.85%)
USD |
NYSE |
Nov 14, 16:00
19.13
0.00 (0.00%)
After-Hours: 20:00
Avanos Medical Revenue (Quarterly): 170.40M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 170.40M |
| June 30, 2024 | 171.70M |
| March 31, 2024 | 166.10M |
| December 31, 2023 | 173.30M |
| September 30, 2023 | 171.30M |
| June 30, 2023 | 169.40M |
| March 31, 2023 | 159.30M |
| December 31, 2022 | 181.60M |
| September 30, 2022 | 172.30M |
| June 30, 2022 | 170.90M |
| March 31, 2022 | 197.40M |
| December 31, 2021 | 35.80M |
| September 30, 2021 | 184.10M |
| June 30, 2021 | 186.40M |
| March 31, 2021 | 180.70M |
| December 31, 2020 | 185.00M |
| September 30, 2020 | 185.70M |
| June 30, 2020 | 163.70M |
| March 31, 2020 | 180.40M |
| December 31, 2019 | 189.80M |
| September 30, 2019 | 171.40M |
| June 30, 2019 | 172.20M |
| March 31, 2019 | 164.20M |
| December 31, 2018 | 169.90M |
| Date | Value |
|---|---|
| September 30, 2018 | 165.10M |
| June 30, 2018 | 160.90M |
| March 31, 2018 | 156.40M |
| December 31, 2017 | 166.30M |
| September 30, 2017 | 150.50M |
| June 30, 2017 | 149.10M |
| March 31, 2017 | 145.70M |
| December 31, 2016 | -616.10M |
| September 30, 2016 | 397.50M |
| June 30, 2016 | 400.00M |
| March 31, 2016 | 384.80M |
| December 31, 2015 | -664.00M |
| September 30, 2015 | 389.50M |
| June 30, 2015 | 389.30M |
| March 31, 2015 | 394.20M |
| December 31, 2014 | 439.40M |
| September 30, 2014 | 408.50M |
| June 30, 2014 | 413.50M |
| March 31, 2014 | 410.70M |
| December 31, 2013 | 431.30M |
| September 30, 2013 | 419.50M |
| June 30, 2013 | 415.90M |
| March 31, 2013 | 410.80M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
35.80M
Minimum
Dec 2021
197.40M
Maximum
Mar 2022
169.76M
Average
172.80M
Median
Revenue (Quarterly) Benchmarks
| Globus Medical Inc | 625.70M |
| NeuroOne Medical Technologies Corp | 0.8258M |
| SINTX Technologies Inc | 0.378M |
| Nutriband Inc | 0.4428M |
| enVVeno Medical Corp | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.30M |
| Total Expenses (Quarterly) | 158.40M |
| EPS Diluted (Quarterly) | 0.09 |
| Enterprise Value | 968.70M |
| Gross Profit Margin (Quarterly) | 54.52% |
| Profit Margin (Quarterly) | 2.52% |
| Earnings Yield | 1.78% |
| Operating Earnings Yield | 3.77% |
| Normalized Earnings Yield | 2.405 |